145 related articles for article (PubMed ID: 17634543)
1. Protein expression profiling and molecular classification of gastric cancer by the tissue array method.
Lee HS; Cho SB; Lee HE; Kim MA; Kim JH; Park DJ; Kim JH; Yang HK; Lee BL; Kim WH
Clin Cancer Res; 2007 Jul; 13(14):4154-63. PubMed ID: 17634543
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China.
Deng J; Zhang R; Pan Y; Wang B; Wu L; Jiao X; Bao T; Hao X; Liang H
Surgery; 2014 Jul; 156(1):64-74. PubMed ID: 24929759
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
[TBL] [Abstract][Full Text] [Related]
5. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
8. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].
Ke B; Liu N; Liang H; Zhang RP; Wang XJ; Wu LL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):543-6. PubMed ID: 23801207
[TBL] [Abstract][Full Text] [Related]
11. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
12. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X
Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061
[TBL] [Abstract][Full Text] [Related]
13. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
14. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling.
Teramoto K; Tada M; Tamoto E; Abe M; Kawakami A; Komuro K; Matsunaga A; Shindoh G; Takada M; Murakawa K; Kanai M; Kobayashi N; Fujiwara Y; Nishimura N; Shirata K; Takahishi T; Ishizu A; Ikeda H; Hamada J; Kondo S; Katoh H; Moriuchi T; Yoshiki T
J Surg Res; 2005 Apr; 124(2):225-36. PubMed ID: 15820252
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
[TBL] [Abstract][Full Text] [Related]
18. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.
Koumarianou A; Tzeveleki I; Mekras D; Eleftheraki AG; Bobos M; Wirtz R; Fountzilas E; Valavanis C; Xanthakis I; Kalogeras KT; Basdanis G; Pentheroudakis G; Kotoula V; Fountzilas G
Anticancer Res; 2014 Sep; 34(9):4949-62. PubMed ID: 25202077
[TBL] [Abstract][Full Text] [Related]
20. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
